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Mice that overexpress a mutated ornithine decarbox-
ylase (ODe) transgene in outer root sheath keratino-
cytes of the hair follicle were used to study the role of 
this enzyme ill regulating hair follicle structure and 
function. These transgenic mice have a nornlal first 
hair cycle, but lose their hair completely beginning 
2-3 wk after birth. Transgene overexpression in fol-
licular keratinocytes is first detected at day 12 after 
birth, coincident with the development of follicular 
cysts in the upper portion of the dermis. The onset of 
keratin 6 expression also begins around day 12; be-
cause the promoter/regulatory region of the bovine 
keratin 6 gene was used to target ODe transgene 
H air growth in mi ce and other mamm~ls. including humans, IS characten zed by a cyclic process of fo lJjcle regeneration/hair growth (anagen), fo Uicl e involution/hair growth cessation (catagen), and a follicle resting stage (telogen). The factors that 
regulate the m ammalian hair cycl e are largely unknown . although 
som e promising candidates have emerged fi'om studies on trans-
genic mice: fibrobla st g rowth factor 5 (Hebert et ai, 1994) and the 
tra nsforming growth factor- {3 superfamily members BMP-2 and 
BMP-4 (Blessing et ai, 1993). Whereas these growth facto rs and 
signaling molecules may be important humoral mediators of follicl e 
growth and regression, what is completely lacking are clues to 
illiface/I,dn,. regulators of hair follicl e activity. In an immunocyto-
chemical analysis of ornithine decarboxylase (ODe) expression in 
murine epidermis IIerSIIS epidermal tumors, Sundberg el al (1.994) 
observed hair cycl e-dependent ODe expression in follic les. In 
telogen follicles, ODe expression was upregulated in a small 
cluster of outer root sheath cell s near the so- ca ll ed "bulge" region , 
whereas in anagen fo Wcles, expression was seen along most of the 
length of the foUicl e. In normal in terfollicular epidermis, elevated 
levels of ODe are never observed unless the skin is treated with 
inducing stimuli such as phorbol es ters (O'Brien el nl, 1.975a; 
Weeks el nl, 1982). 
In experimental models of skin carcinogenesis (large ly mouse 
models), several li nes of evidence suggest that non-melanoma 
tumors frequently arise fi'om presumptive stem cells of the hair 
follicle (reviewed in MiHer et nl, 1993). Based on previous work in 
the two-stage model of skin carcinogenesis (O'Brien el nl, 1975b; 
O'Brien, 1976), we hypothesized that constitutive overexpression 
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expression to hair follicle keratinocytes, these data 
demonstrate the faithful temporal and cell type-
specific expression of the K6-driven transgene. The 
ODe inhibitor 2-difluoromethylornithine could pre-
vent hair loss and partially normalize skin histology if 
adlninistered before the onset of ODe overexpres-
sion. 2-Difluoromethylornithine could also reacti-
vate hair growth in animals with complete hair loss. 
Our results suggest that ODe is an important regu-
latory gene for the mouse hair follicle. Key lVords: 
poi)lamilles/2-dijiIlOJ'Ollletil),iol'llitllille. ] Invest Derlllatoi 
106:1108-1113, 1996 
of ODe might enhance susceptibili ty of epidermal keratinocytes to 
neoplastic transformation. We therefore decided to construct trans-
genic mice that constitutively overexpress ODe in haiJ" foHicle 
keratinocytes. The resulting transgenic mice, which overexl'ress 
ODe in outer root sheath keratinocytes, indeed exhibit a high 
frequency of spontaneolls skin tumors, including keratoacantho-
mas, which are knowlI to develop fi'om hair follicles (Megosh et nf, 
1995). One of the other interes ting phenotypes of these transgenic 
mice was hair loss beginning at 2-3 wk of age, when the second 
cycle of hair growth would be expected to begin. Histologic 
ana lysis of the skin of adult transgenic mice with complete hair loss 
revealed foll icular cysts in the dermis that progressively increased in 
size as the anima ls aged (Megosh el nl, 1995). Because ODe is an 
enzyme for which potent inhibitors are availab le, we decided to ask 
whether modulation of ODe transgene activity coul.d iJlftuence 
hair fo llicle function in these mice. If so, these transgenic mice 
could be a usefu l experimental model to ana lyze intrinsic and 
extrinsic f.~ctors that regulate the mammalian hair follide. 
MATERIALS AND METHODS 
Transgenic Mice The pro ductio n of transgeni c Inice that ovcrcxprcss a 
mutated ODC specifica lly in skin has becn described in detail e1sewhcre 
(Mcgosh e/ "I, 1995) . For the cxperimcnts described herein, transgenic 
progeny from the founder line designated KG-55 were used. The ODC 
transgcll c is rnaintail1cd in the he mizygo us state by lIlatings of transgenic 
with B6C3Fl mice. Typic:dly, male hc,nizygous transgenic mice arc mated 
with normal J36C3Fl female ll1ice to generate approximately cqllaluumbers 
of transgeni c pups and Ilolltrallsgcni c li ttcfmates. W hen necessary, poly-
m era se eha_in reaction ana lysis of tni l DNA was used to identify transgenic 
(nice, as described prcviously (Megosh C!I nl. 1995). When 2-diAuoroll1ethyl-
ornithin e (.DFMO) was <ldnlil1_istc red. it was dissolved ill drinking water at 
a con centration of 1 (Yr. (w / v). 
I'l1munocytochclnistry Skin for both routine histology and ilTlIl1UUO-
cytochCllli stry was fixed overnight in Fekete's solu tioll (o l lXl etha1lol , 3._% 
formaldehyde, 0.75 N acetic acid) and embedded in paraffin . hnrnunoc),-
tochClTIistry was pc[[onncd 011 5-p.M sections using rabbit anti-ODC 
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Figure 1. Transgenic mice have nllJltiple skin abnormalitics. 
Shown are a transgenic mouse (ballolll) and its normal li ttermate, derived 
from a B6C3 F1 X fo under cross. Note excessive skin fo lds, wrinkling, and 
longer th an n o nllal na ils in the transgenic 1l10 llSC. 
antiserum at '1 :3, 000 and a rabbit anti-moll se ){ (, antiserum at I :8,000. with 
an avidin-biotin detection system (Vector Laboratori es . Burlingame. CAl. 
ODC and Polyaminc An alyses Skin specimens were separated in to 
epidermal and derl11 al Ii'actions by bri ef heat treatment (55°C, 20 s) , 
followed by scraping with a razor blade. T issues were homogenized in 
buffer (25 111M Tris-HCI, pH 7.5, containing 1 mM dithiothrcitol and 0. '1 
mM ethylenediamine tetraacetic acid) or 0. _ N pcrchlori c acid fo r O DC and 
poiyanline analyses, respecti vel y. Assays were conducted exac tl y as de-
scribed previously (Koza c( nl , 1991). For ODC activity , 1 uni t = I nnlOl 
CO2 liberated/ h at 37°C. 
R ES ULTS 
Transgenic Mice That Ove rexpress ODC Have Multiple 
A bnornlalities Except fo r smalie r size, transgenic mi ce of bo th 
sexes appeared pheno typically Jl o rmal fo r approxima te ly 2 w k afte r 
birth. They then exhibited progress ive hair loss, including vibrissae, 
which w as complete by 6 wk o f age. Unless specifica lly treat.ed (see 
below), alo pecia was irrevers ible. Nail growth was also acce lerated, 
and as the ani mals aged, the skin became increasing ly w rinkled and 
folde d because of the increase in size and number o f derm al 
fo llic ular cys ts. Early in life, transgenic mice were smaller than 
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normal littermates, but with age, transgenic animals ~I chieved 
similar weights as nOlTIlall11ice. T he weight distribution , however, 
was o bviously very different; am ong mice o f similar weigh t, the 
skin o f norm al mice represented 25% of total carcass weigh t, 
w h ereas in older transgenic mice, skin weigh t w as 55°!., of total 
carcass weight beca use of th e grea ter area and thickness of the skin 
(A . Peralta So ler and T. G. O 'Brien , unp ublished data). A trans-
geni c m o use and a no rmal age-matched li tte rmate are shown in Fig 
1. 
T he phenotype of these mice resembles in som e respects that of 
rhino mice, an alle lic va rian t o f the hairless (lt r/"r) m ouse (M ann, 
1971) . Although the integration site o f th e O D e transgene has not 
yet been m apped, it is very unlikely tbat it is at the Itr locus on 
chrom osome 14; offspl·ing from six differen t founders all d isplayed 
the same phenotypi c m ani fes tations. Moreover, the ODe transgcne 
acts in a dominant m anner, w hereas the It,. mutation is recessive. 
Morphologic Changes a nd Transgene Expression Firs t Ap-
pear at About D ay 12 Afte r Birth In transgenic m ice that 
overexpress O D C, the first hair g ro wth phase was norm al bu t 
subsequent cycles did not occur. To determine the timing of the 
onse t of transgene express ion rela tive to m orpho logic changes, we 
euthanized non transgenic and transgenic pups at 2- to 3-d in te rva ls 
from 2 to 23 d after birth and prepared skin sections for histology 
and iml'l1unocytochemist.y . T here w as no o bvious di ffe rence in skin 
histology between non tran sgenic and transgenic li tte rmates un ti l 
day 12 postnatally, w hen sm all fo llicul ar cysts and m oderate 
sebaceous ce ll hyperplasia were observed in transgenic skin (Fig 
211). By day 23, the follicle-de rived cysts were larger and more 
num erous, and no rm al fo llicl es were absen t (Fig 2d). In terms of 
O D e express ion, up to 10 d afte r birth the re were no apparen t 
difte rences in th e patte rn of ODC express ion in transgenic ("TSI/S 
nontransgenic skin as determin ed immun ocytochem ically (data n o t 
shown). At 12 d, however, there was elevated ODe expression in 
som e develo ping cysts and fo llicul ar areas of th e tr ansgenic skin 
(Fig 2/1) compared w ith con tro ls (F ig 2a) . By 23 d, ODe overex-
pression in transgenic skin w as clearl y associated w ith developing 
pilar and follicul ar cys ts (Fig 2d) , w ith weaker expression in 
fo llicles of normal skin (Fig 2c). 
T he resul ts of irnmunocytochem ical analysis of ODe expression 
in newborn mice of di ffe ren t ages suggested that the fi rst. signs of 
fo llicular abnormali ties were o bserved in the upper portion of th e 
fo llicle (i. e., th e in fundibulum). As shown in Fig 3 , at 16 d there 
was clear c:! vidence o f incip ien t cys t fo rma tion in the upper half of 
the fo llicle, w hereas the lower half o f the fo Uicle, incl ud ing the hai r 
bulb and demlal papilla, appea red no rm al. Inspection of multiple 
sec tions of h ill- length fo llicles fro m 12- to 16-d o ld anima ls did not 
Figu re 2. ODC is o vcrex prcsscd in folli c le s and ill i.ncipient cys ts of transg enic Ill.i c c. Pups [ro ln a fiGC3F1 s transgenic crOSS were e uth:1Il izcd 
at vario lls da ys after b irth. skin sa mples Vlcrc tak e n fo r histologic an d inll11unocytochcnti ca l anal ysis. an d li ver tiss ue was removed fo r pO l rnlc r~l sc ch ai n 
reaction determination oftransgcnc starus . n,", Sections From nontr;lIlsgcnic pups at 12 and 23 d aftc r birth, respective ly; !>,ri, transgenic pups at the same ages. 
Scale bar, 100 J.un. 
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Figure 3. Abnormalities first develop in the upper portion of follicle. Histology is shown for normal (a) and transgenic (b) skin at 16 d. Note 
incipien t cysts in the infundibular area (ntTOIIIS) and normal-appearing hair bulb and dermal papilla in transgenic skill . Senle bar, 300 /L1ll. 
reveal any obvious abnormalities of the lower fo llicle (including the 
hair bulb) in transgenic mice. 
If, as is likely, the more intense staining of ODe in transgenic 
skin at day 12 and therea fter is due to activation of transgenc 
expression (as opposed to expression of the endogeno us ODe 
gene), then there may be a temporal association between the onse t 
of keratin 6 promoter-driven ODe expression and keratin 6 
expression itself. T his question was addressed using the same series 
of skin sections analyzed for ODe expression, except that a 
polyclonal anti-K6 antiserum was used ins tead. As shown in Fig 
4a,b, there was no evidence of K6 express ion in eithe r no rmal or 
transgenic skin at 4 d postna tally. T here was also no histologic 
diJfe rence observed at this time. T he first evidence ofK6 expression 
was seen at day 12 in non transgenic mice. Expression was restricted 
to the o uter root sheath of anagen hair fo llicles in the mid-dermis 
(Fig 4c); this is the predicted expression pattern based on the resu lts 
of others (Heid el ai , 1986; R ami rez el ai, 1995). Inte restingly, K6 
staining of transgenic skin revealed a different expression pattern: 
Follicles on the mid-dermis were negative, but weak stain ing was 
detected in fo llicles of the upper dermis, some of which appeared to 
be incipient pilar cysts (Fig 4d) . This is ve ry similar to the 
express ion pattern for ODe at day 12 in transgenic mice (Fig 2d). 
By day 23, virtually all hai r fo llicles in non transgenic mice w ere 
positive (Fig 4e) , whereas K6 expression in transgenic mice was 
generally restricted to fo ll icu lar cysts (Fig 4j) . 
DFMO Prevents Hair Loss To determine whe ther elevated 
transgen e expression was directly responsible for the hair-loss 
phenotype, we used DFMO, the irreversible inhibi tor of ODe. 
T his compound has been used in mice previo usly and is both 
effective at inhibiting ODe and well tolerated at doses of up to 2% 
in the drinking water (Weeks ct ai, 1982; Takigawa el ai, 1982; 
Kingsnorth el ai, 1983) . Newbom pups, both transgenic and 
nontransgenic, were administered DFMO at 1% (w/v) in their 
dam 's drinking water. At weaning, transgenic mice (identified by 
polym erase chain reaction analysis of tai l DNA) were divided into 
two groups: O ne group was switched to regular drinking water, 
and one group continued to receive drinking water containing 1% 
DFMO. Typically, weanling transgenic mice had lost most Of all of 
their hair, but mice administered DF MO were indistinguishable 
from normal B6e3F2 mice. All transgenic mice (n = 4) adminis-
te red DFMO fi'om birth con tinued to maintain nOfmal-appearing 
ha ir coats, w hereas those mice switched to regular drinking water 
at week 3 graduall y lost hair and develo ped the thickened , wrinkled 
skin rypical of transgenic mice never exposed to DFMO (Fig Sa) . 
Histologically, skin from a tran sgenic mouse maintained continu-
ously on DFMO had no rmal, haiT-contain.ing fo llicles (Fig 51/) , 
w hereas skin from a m o use returned to regular drinking water had 
typical follicle-derived cysts (Fig Sc). Foll icle den siry in transgenic 
mice maintained continuously on DFMO was, however, less than 
that in Ilontransgenic skin of the sam e age. 
Previo us results had indicated that ODe transgene overexpres-
sion in skin occurs predomin antly in the dermis, where folli cular 
cysts are localized (M egosh cl ai, 1995). DFMO treatment wa 
clearly effective in inhibiting ODe activity in transgenic dermis 
(Table I). Withdrawal of DFMO led to '1 recovery of transgene 
expression, but not to levels typicall y observed in untreated 
transgenic dermis (Megosb el ai, 1995; T.G . O'Brien , unpublished 
results). Putrescine I.evels reflected the re lative ODe activities in 
transgenic skin (continuous DFMO and DFMO-withdrawn) and 
nontransgenic skill , whereas, curiou sly, spe rmidin e and spermine 
levels did not; both were e leva ted in each of the transgenic 
treatment gro ups IICI"S IIS normal dermal leve ls of these polyam.ines 
(M egosh cl ai, 1995). T he explanation for the eleva tions in 
spe rmidine and spermine .l evels in m ice con tinuously administered 
a concentration ofDFMO that completely inhibits ODe expression 
is not known. T hus, it appears that putrescine levels, and nor 
spermidine or spermine, in the dermis correlate best with hair 
growth status: N ormal (low) leve ls of putrescine are permissive for 
no rmal hair fo llicle activity, whereas high levels disrupt the hair 
cycle. 
DFMO Reactivates Hair Growth To address the question of 
w hether transgene inhibi tion in o lder animals with complete hair 
loss could reactivate ha ir growth , we administered DFMO (at 1%) 
in the drinking water to 6.5- wk-old transgenic mice with no 
normal hair fo llicles in the skin. After 2 wk of DFMO administra-
tion, hai r growth in all treated mice (n = 3) had begnn (compare 
Fig 6a vcrs lI .\" 6b) , and by 9 wk of drug trea tment, substantial hair 
growth had occurred (compare F ig 6c vef SII .\" 6d) . Compared witb 
control transgenic skin (Fig 6e) , DFMO-treated skin contained 
normal hair follicl es, w ith fewer and smaller follicular cysts (Fig 6j) . 
As expected , ODe and po lyamine levels were also normalized in 
DFMO-treated skin (Table II). T hese results indicate th at trallS-
gene expression sufticient to cause complete hair loss does not 
irreversibly impair the abiliry of fo llicle stem cells to generate 
normal hair fo llicles . 
D ISCUSSION 
The transgenic m ouse model we have described here and elsewhere 
(M egosh eI ai , 1995) implicates ODe as a gene that, when 
overexpressed, can disrupt hair fo llicle structure and function. W e 
presume that the effects of ODe overexpression are mediated by 
the substantial elevation s ill putrescine, and to a lesser extent, 
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Figure 4. K6 expression is first observed on day 12 after birth. 
Res ults a re shown for K6 immunocytochemistry of mice at 4 d (a ,ll) , 12 d 
(c, d). and 23 d (eJ) after birth . a,c,c, NOlltntnsgcl1ic skill; b,dJ; tr'lIl sgclli c 
skin. Scale bar, '100 l .. tll1 . 
spermidine, tbat are o bserved in the dermis of transgenic mice, 
because no functions o the r than its enzym atic activity have been 
rigorously ascribed to ODC. ODC is almost always a very low 
abundance protein in normal adult m ammalian tissues, but Sund-
berg et al (1994) have reported high levels of ODC expression in 
anageD h air follicles, compared with m ore restricted expression in 
telogen follicles of adult CD-l mice. This follicular stage-specific 
expression of ODC in a no rmal o utb red mouse and o ur results in 
transgenic mice overexpressin g ODC are consistent w ith the 
fo llowing hypothetical ro le for ODC (and polyamines) ill fo llicle 
behavior. Loca l m ediators (fibroblast growth factors, EMPs?) in-
duce ODC in a transitory fashion to trigger the anagen phase of 
folljcle g rowth . Enzym e activity (and follicle growth) is m aintained 
by the con tinuo us presence of mediator substances. When the local 
concentration of exogen ous r.,ctor(s) declines, ODC is de-induced , 
and follicles enter the catagen phase. If ODC activ ity is constitu-
tively expressed at a very h igh level (as in transgenic mice). the 
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resulting higb levels of intrace llular polyamines suppress no rmal 
fo llicular behavior and instead favor continuous proliferation of 
outer root sheath keratinocytes to form fo lljcul ar cySts .. At least 
som e cell s iu these cysts, h owever, reta in stem cell capability once 
ODC and polyamine levels are reduced to normal values (e.g. , via 
DFMO admilustration) . 
T he bovine K6 promoter used to drive ODC tran sgene expres-
sion in this m ouse m odel appears to direct ODC expression to the 
"correct" cell type in skin (outer root sheath keratinocytes), based 
on what is known abo ut mouse keratin 6 expression (Heid el nl, 
198G) . In o ur comparative analysis of ke ratin G expression in normal 
mice /lers" s K6-driven ODC expression in transgenic mice, we also 
o bserved that expression of both genes begins at the sa me time afte r 
birth (approximately 12 d) . Our time course analysis (every 2 d 
after birth) of both skin histology an d expression of KG and ODC 
in this transgenic m odel indicated tllat the first evidence offolljcula.r 
cys t development w as observed at 12 dafter birtll , coincident with 
the onset of both endogenous KG expression and ODC overex-
pression .. C learly, ODC ovcrexprcssion due to activation of the 
KG-driven transgene drives the developm ent of abnormal skin 
lustology and hair follicl e dysfun ction in this model. 
Important tests of the idea tllat ODC ac ti vi ty is a regulator of hair 
follicl c function involved the use of a highly specific inhibito r, 
DFMO, either to preven t the onset of ODC overexpression or to 
rcduce es tablished overexpression to m ore no rmal lcvels. Admin-
istration of this drug immediately after birth , before tl'ansgene 
expression was turned on , was very effective in preventing higb 
levels of ODC expression and hair loss .. Somewhat surp,-isingly, 
administration of the drug after high levels of ODC transgene 
express ion had been established (and hair loss was comple te) 
resulted in reactivation of hair growth, although a comple tely 
normal ha.ir coat was not achieved . R eappearance of normal 
follicles was accompanied by shrinkage and actual disappearance of 
som e of the follicular cysts characteristic of adult t.ransgenic micc. 
T his result suggests that at least somc cells in the cysts retain stem 
cell potential. We concludc from both sets ofDFMO cxperiments 
that intracellular polyamine levels (especially putrescine) act as a 
mol ecular switch regUl ating the behavior of outer root shea th 
keratinocytes of the hair follicle: H igh levels support proli fe ration 
and suppress difFe rentiation, w hereas low levels are permiss ive fo r 
differentiation but not permissive for prolifen'tion. In normal mice, 
polyamine levels would flu ctuate in response to transient elev<Itions 
of ODC ca used by extracellular factors produced either loca ll y or 
systemically, w hereas the con stitutive overexpress ion of ODC in 
tra.nsgenic mice wou ld eliminate fl uctuations ill polyamine levels 
and abrogate exogeno us con tro l of fo llicular keratinocyte growth 
and differentiation .. 
Alth ough there are numerous mutations tha c cause hai.r loss in 
mice, the iden tity of the genes involved is not known in most cases 
(Sundberg, 1994) . Interesting ly, mutations in another gene in-
volved in ornitlunc m eta bo lism , orn ithine transcarbamylase , are 
responsible for the "sparse fur" phenotype (Doolittle et nl , 1974; 
D eMars eI nl, 1976). In transgenic mice, overexpression of a sheep 
wool keratin gene caused cyclic hair loss and regrowth (Powell and 
Rogers, '1990) .. In addition. transgenic mice ovcrexpressing the 
Table I. DFMO Prevents the Increase in ODC and 
Polyaminc Levels in T ransgenic Mice" 
ODe 
Trcatl11Cnt (U / mg Protcin) 
DFMO continuo us s O.O I 
DFM O 3 wk, 
thell off t 2 wk 6.63 
I'u 
Pol ya111inc 
(nmollmg D NA) 
5pd 
29.8 844 
477 12 12 
51' 
7 12 
323 
" The mi ce dcpictcci ill Fig 5" w ere c urh au izcd . ;lna c;xtr:l cts of d ermis were 
nnalyzcd fLlr ODC activir), ann po ly;uninc levels 3); described in J\ li fllcrif1/s nfld A1t'tl/{)ds. 
Pu. putrescine; Spd . sperm idine; Sp. sperminc. 
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Figure 5. DFMO prevents hair loss. Transgenic mice who were administered DFMO either continuo usly (n; lift) or only for the first 3 wk of life (n: right) 
were euthanized at 15 wk of age, and their skins were examincd hi stologicall y and for tmnsgenc expression . Ii, hematoxylin and eosin-stained section of skin 
from the mOllse administered DFMO continuo usly; C, section fi'om the mouse administered DFMO for 3 wk after birth , then switched to regular drinking 
water. Note the prcsence of normal hair-containing follicles in II and a develop ing follicular cyst in r. Srnle bnr, 100 1.1.111. 
Figure 6. DFMO reactivates hair growth ill trans-
genic mice with complete hair loss. Forty-f.ve-day-
o ld transgenic J11i ce were either maintained 011 their 
regular drinking water (n,r) or switched to drinking water 
containing 1'% DFMO (b, r/). Mice were photographed 17 
d (n, ll) or 67 d (c, r/) late r. Mice pictured in c and d were 
then ellthanized, and skins we re analyzed histologica ll y 
(cJ) and for transgene expression (Tablc II) . Note the 
presence of a normal fo llicle with hair in the skin from the 
m OllSe administered DFMO (f). Senle bnr, 100 1-1.111. 
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Table II. DFMO Reduces the Elevated ODC and 
Polyamine Levels in Transgenic Mice" 
ODC 
T rc atrncnt (U / l11g Protein) 
o ne 22.5 
DFMO, 9.5 wk 1.4 
I'll 
1020 
PoI yalllinc 
(11l1lol/ l11g DNA) 
Spd Sp 
2134 545 
49.6 715 795 
fI T h e mice depicted ill Fig 6c,d were 1.!1Ithallizcd, and extracts of dermis were 
analyzed for O DC :Iclivity and polyamine levels. Abbreviations ns in Table J. 
tran sforming growth fa ctor-related polypeptide BMP-4 driven by a 
K6 promoter exhibit a partial hai.r-Ioss phenotype (Blessing ct nl , 
1993) . The enzymatic activity ofODC in transgenic dennis can be 
effectively inhibited by a nontoxic (J %) concentration of DFMO in 
rhe drinking water. Other approaches such as an inducible trans-
genj c expression systel11 (Furth ct nl, 1994) could also be used to 
regul a te ODC expression levels. Using such models, it should be 
possible to study the mechanisms involved in the loss ofnorl11al hair 
follicles and the morphogenesis of new follicl es, as well as the 
extrinsic fa ctors that regulate these events . 
Finaliy, does ODC regulate the hair follicle structure and func-
tion in other mammals, including humans? Because DFMO is being 
actively evaluated as a cancer chemopreventive agent, there have 
been several long-term chronic toxic ity studies of DFMO in both 
animals and humans. Takigawa et nl (1983) reported that the only 
side e ffect of J % DFMO ill the drinking water in mice undergoing 
long-te rm anti-carcinogenesis experiments was "severe re tardation 
of hair growth ." A l-year study of daily oral administration of 
DFMO to dogs and rats reported moderate to severe dermatologic 
reactions , including alopecia, dermatitis, and conjunctivitis (Crow-
ell et aI, 1994). In humans, the dose-limiti.t1g toxic effect of this 
compound is ototoxicity (Love el nl, 1993) , which is usually caused 
by chemically induced damage to the outer hair cells of the inner 
ear (Harrison , 1988). The fiuding that hair folljcl es and inner-ear 
hair cells are among the most sensitive cell types to ODe-targeted 
drug treatment suggests that polyamines are critically important 
mole cules in regulating the growth and fun ctioning of these 
specialized tissues. D efects in polyamine metabolism. therefore, 
may underlie some abnormalities of skin and hair growth in 
humans . If so, polyamine-based therapies may have potential for 
the treatment of such diseases. 
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